Project Grant R01MH139377
Award Date
1/15/25
Completion Date
10/31/29
Dollars Obligated
$679K
Federal Agency
National Institute of Mental Health
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Illinois, USA
Similar Awards
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $1,668,032.00 to the University of Pittsburgh to conduct research into the mechanisms of HIV-1 latency in the central nervous system (CNS). The primary objectives are to identify key factors, pathways, and regulators that control the establishment, maintenance, and reactivation of latent HIV-1 reservoirs in CNS myeloid cell lineages,...
This $1,537,749 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to investigate the molecular mechanisms by which HIV proteins and methamphetamine activate the astrocyte-specific NLRP6 inflammasome, leading to neuroinflammation in the context of HIV-associated neurocognitive disorders. The award, with a project period from July 1, 2024 to April 30, 2029, will support in vitro, ex vivo, and in vivo...
This $818,886 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) will support research at the University of California, San Diego (UCSD) to characterize the epigenetic regulation of the HIV provirus in brain myeloid cells from people with HIV (PWH). The key objectives are to: 1) Analyze the epigenetic characteristics of the HIV provirus in brain myeloid cells from 15 PWH, 2) Explore the mechanistic...
The National Institute of Mental Health (NIMH) awarded a Project Grant (CFDA 93.242 - Mental Health Research Grants) in the amount of $403,488.00 to The Children's Hospital of Philadelphia Research Institute. The grant, which runs from August 26, 2024 to March 31, 2027, will fund research to determine how HIV and antiretroviral therapy (ART) affect lipid metabolism in oligodendrocytes and astrocytes, and the impact on myelination during adolescent brain development. The goal is to identify...
This Project Grant award of $881,439 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support research to better understand the evolution and latency of T-tropic and M-tropic HIV in people infected with subtype C virus. The key objectives are to: Determine the frequency of macrophage-tropic virus evolution within the central nervous system (CNS), 2) Identify which cell types in the CNS are expressing virus, 3) Examine how...
This $983,672 Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) supports research to characterize the in-situ interactions between HIV-infected cells and the central nervous system (CNS) in people living with HIV (PWH), with a focus on understanding the impact of methamphetamine use. The project aims to develop and implement innovative spatial multi-omic assays to analyze the localization, distribution, and activity of...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support research to investigate the relationship between HIV-related cognitive impairment and biological aging. The $168,407 award to The Washington University will fund a 5-year study that will utilize measures of epigenetic age acceleration and brain age acceleration, along with machine learning techniques, to develop predictive models of cognitive...
This federal Project Grant award, valued at $383,750.00, was provided by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866). The primary objective of the grant is to study the molecular, neuro-immune, and behavioral changes that occur during HIV-associated progressive aging using a long-term humanized mouse model. Key research activities include: Evaluating the impact of HIV latency and antiretroviral therapy (ART) on premature aging and functional...
This federal Project Grant award for $745,822, provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), is supporting research to investigate the role of the PERK enzyme in HIV-induced neuroinflammation and neurocognitive impairment. The project, led by the University of Pennsylvania, is employing biochemical, cellular, and pharmacological approaches to assess how PERK activity and signaling in different cell types (neurons,...
The National Institutes of Health (NIH), through the Mental Health Research Grants program (CFDA 93.242) administered by the National Institute of Mental Health (NIMH), has awarded a $434,500 R21 grant to the University of California, San Diego (UCSD) to investigate the epigenetic mechanisms controlling HIV latency and neuropathogenesis in microglia. The project aims to use single-cell multi-omics approaches and state-of-the-art sequencing technologies to characterize the transcriptomic and...